Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in Germany

Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in Germany

2005 ECCO 13: The European Cancer Conference, October 30 - November 3, 2005, Paris, France

Aballea, S. | Frick, M. | Diel, R. | Rosenfeld, S. | Huppertz, R. | Sievert, M. | Jourdan, S. | Drummond, M. | Weinstein, M. | Reidchardt, P. | Volume: , Issue: , Pages: , cost-effectiveness analysis, analysis, colon cancer, Germany,